Fig. 3From: Minimal change disease associated with anti-PD1 immunotherapy: a case reportSerum albumin (primary y axis, red squares with trend line) and 24-h urine protein excretion (secondary y axis, blue diamonds with trend line) longitudinally over the anti-PD1 treatment coursesBack to article page